相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。From Experiments to a Fast Easy-to-Use Computational Methodology to Predict Human Aldehyde Oxidase Selectivity and Metabolic Reactions
Gabriele Cruciani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Refinement of In Vitro Methods for Identification of Aldehyde Oxidase Substrates Reveals Metabolites of Kinase Inhibitors
Ryan A. Dick
DRUG METABOLISM AND DISPOSITION (2018)
Recent advances in the discovery of small molecule c-Met Kinase inhibitors
Palak K. Parikh et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
A General Strategy for Site-Selective Incorporation of Deuterium and Tritium into Pyridines, Diazines, and Pharmaceuticals
J. Luke Koniarczyk et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Metabolism of c-Met Kinase Inhibitors Containing Quinoline by Aldehyde Oxidase, Electron Donating, and Steric Hindrance Effects
Jiang Wei Zhang et al.
DRUG METABOLISM AND DISPOSITION (2018)
Evaluation of Deuterium-Labeled JNJ38877605: Pharmacokinetic, Metabolic, and in Vivo Antitumor Profiles
Zhengsheng Zhan et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2018)
Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy
Paolo M. Comoglio et al.
NATURE REVIEWS CANCER (2018)
Identification of 3-substituted-6-(1-(1H-[1,2,3]triazolo[4,5-b]pyrazin-1-yl)ethyl)quinoline derivatives as highly potent and selective mesenchymal-epithelial transition factor (c-Met) inhibitors via metabolite profiling-based structural optimization
Fei Zhao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Aldehyde Oxidase Mediated Metabolism in Drug-like Molecules: A Combined Computational and Experimental Study
Yuan Xu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Structure-metabolism relationships in human-AOX: Chemical insights from a large database of aza-aromatic and amide compounds
Susan Lepri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Discovery and optimization of a series of imidazo[4,5-b]pyrazine derivatives as highly potent and exquisitely selective inhibitors of the mesenchymal-epithelial transition factor (c-Met) protein kinase
Fei Zhao et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Discovery of 6-(difluoro(6-(4-fluorophenyl)-[1,2,4]triazolo[4,3-b] [1,2,4]triazin-3-yl)methyl)quinoline as a highly potent and selective c-Met inhibitor
Zhengsheng Zhan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
The c-Met Tyrosine Kinase Inhibitor JNJ-38877605 Causes Renal Toxicity through Species-Specific Insoluble Metabolite Formation
Martijn P. Lolkema et al.
CLINICAL CANCER RESEARCH (2015)
Design, synthesis and molecular docking analysis of some novel 7-[(quinolin-6-yl)methyl] purines as potential c-Met inhibitors
Lianbao Ye et al.
MEDICINAL CHEMISTRY RESEARCH (2015)
A Novel Reaction Mediated by Human Aldehyde Oxidase: Amide Hydrolysis of GDC-0834
Jasleen K. Sodhi et al.
DRUG METABOLISM AND DISPOSITION (2015)
Targeting Receptor Tyrosine Kinase MET in Cancer: Small Molecule Inhibitors and Clinical Progress
J. Jean Cui
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery of (S)-1-(1-(Imidazo[1,2-a]pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-[1,2,3]triazolo[4,5-b]pyrazine (Volitinib) as a Highly Potent and Selective Mesenchymal-Epithelial Transition Factor (c-Met) Inhibitor in Clinical Development for Treatment of Cancer
Hong Jia et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Indazoles as potential c-met inhibitors: Design, synthesis and molecular docking studies
Lianbao Ye et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Lessons from (S)-6-(1-(6-(1-Methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)ethyl)quinoline (PF-04254644), an Inhibitor of Receptor Tyrosine Kinase c-Met with High Protein Kinase Selectivity but Broad Phosphodiesterase Family Inhibition Leading to Myocardial Degeneration in Rats
J. Jean Cui et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Effect of Structural Variation on Aldehyde Oxidase-Catalyzed Oxidation of Zoniporide
Deepak Dalvie et al.
DRUG METABOLISM AND DISPOSITION (2012)
A Drug Resistance Screen Using a Selective MET Inhibitor Reveals a Spectrum of Mutations That Partially Overlap with Activating Mutations Found in Cancer Patients
Ralph Tiedt et al.
CANCER RESEARCH (2011)
In silico and in vitro pharmacogenetics: aldehyde oxidase rapidly metabolizes a p38 kinase inhibitor
X. Zhang et al.
PHARMACOGENOMICS JOURNAL (2011)
Case report of extensive metabolism by aldehyde oxidase in humans: Pharmacokinetics and metabolite profile of FK3453 in rats, dogs, and humans
Takafumi Akabane et al.
XENOBIOTICA (2011)
C-MET as a new therapeutic target for the development of novel anticancer drugs
Israel Canadas et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2010)
A Single Amino Acid Substitution Confers High Cinchonidine Oxidation Activity Comparable with That of Rabbit to Monkey Aldehyde Oxidase 1
Kensuke Fukiya et al.
DRUG METABOLISM AND DISPOSITION (2010)
Aldehyde Oxidase: An Enzyme of Emerging Importance in Drug Discovery
David C. Pryde et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Developing c-MET pathway inhibitors for cancer therapy: progress and challenges
Xiangdong Liu et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Species-Specific Metabolism of SGX523 by Aldehyde Oxidase and the Toxicological Implications
Sharon Diamond et al.
DRUG METABOLISM AND DISPOSITION (2010)
THE KINETIC ISOTOPE EFFECT IN THE SEARCH FOR DEUTERATED DRUGS
Liming Shao et al.
DRUG NEWS & PERSPECTIVES (2010)
Is 1-Aminobenzotriazole an Appropriate in Vitro Tool as a Nonspecific Cytochrome P450 Inactivator?
Collette D. Linder et al.
DRUG METABOLISM AND DISPOSITION (2009)
Purification and Mechanism of Human Aldehyde Oxidase Expressed in Escherichia coli
Joshua F. Alfaro et al.
DRUG METABOLISM AND DISPOSITION (2009)
Development and Evaluation of Oral Controlled Release Chlorpheniramine-Ion Exchange Resinate Suspension
A. U. Kadam et al.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Use of density functional calculations to predict the regioselectivity of drugs and molecules metabolized by aldehyde oxidase
Rhonda A. Torres et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Inhibitory effects of Ruta graveolens L. extract on guinea pig liver aidehyde oxidase
P Saieed et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2006)
Drug-metabolizing ability of molybdenum hydroxylases
Shigeyuki Kitamura et al.
DRUG METABOLISM AND PHARMACOKINETICS (2006)
The conduct of in vitro and in vivo drug-drug interaction studies: A PhRMA perspective
TD Bjornsson et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration
C Dittrich et al.
EUROPEAN JOURNAL OF CANCER (2002)
Inter-species variation in the metabolism and inhibition of N-[(2′-dimethylamino)ethyl]acridine-4-carboxamide (DACA) by aldehyde oxidase
PC Schofield et al.
BIOCHEMICAL PHARMACOLOGY (2000)
分享论文
